GlaxoSmithKline (GSK) Launches (Paracetamol) Panadol in the Philippines

“Pain is one of the greatest personal, social and economic burdens faced by people around the world,” said John Sayers, President Consumer Healthcare, Asia, Pacific and Latin America, GlaxoSmithKline (GSK) at the recent Philippine launch of (Paracetamol) Panadol®.

“Panadol has helped people find pain relief across 85 countries for over 50 years and today we are pleased to bring this leading paracetamol brand to Philippines’ consumers. This is a significant milestone for GSK in line with our global commitment to help people do more, feel better and live longer,” he added.

GSK, a global leading healthcare company announced the brand entry and launch of the new (paracetamol) Panadol with Optizorb®.  The brand is one of the world’s leading paracetamol-based pain relievers. Last year alone, 15 billion (paracetamol) Panadol tablets were sold worldwide.

According to Sayers, “The brand is testament to our customers’ trust and faith in the product which boasts an extensive scientific research breakthrough such as the Optizorb technology in our new Panadol.”

Panadol with Optizorb is the only paracetamol brand with the unique Optizorb disintegration system. This is what allows the release of its medicine in as little as five minutes versus regular paracetamol tablets. Studies conducted by GSK have proven that 75 percent of people who take Panadol with Optizorb caplets reach pain relieving levels of paracetamol in the bloodstream significantly faster than those taking other generic pain relieving brands.

The greater rate of absorption enables (paracetamol) Panadol with Optizorb to deliver therapeutic concentrations that helps relieve a variety of pain in people, including those with common medical conditions such as stomach problems and heart disease.

Similar to the broad suitability associated with standard paracetamol, Panadol with Optizorb is well tolerated and will not irritate the stomach when used as directed.

A study conducted in the Philippines found that 7 out of 10 Filipinos suffer from regular headaches, and over half from muscle aches and pains in the past three months. "These pain sufferers have indicated fast relief of pain  is of core importance and this has encouraged us to provide a fast and effective solution like Panadol with Optizorb to alleviate this health condition,” expressed Jeoffrey Yulo, General Manager Consumer Healthcare, GSK Philippines.

The new (paracetamol) Panadol with Optizorb will be available at all leading drugstores nationwide, starting February 2014. It comes in 36 x 10s dispenser box and each 10s catch cover has an SRP of P32.00. For more information on pain management, please visit www.Panadol.com.